Mujie Kan

456 total citations
12 papers, 336 citations indexed

About

Mujie Kan is a scholar working on Molecular Biology, Pharmacology and Pharmaceutical Science. According to data from OpenAlex, Mujie Kan has authored 12 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Pharmacology and 2 papers in Pharmaceutical Science. Recurrent topics in Mujie Kan's work include Berberine and alkaloids research (2 papers), Fibroblast Growth Factor Research (2 papers) and Nanoplatforms for cancer theranostics (1 paper). Mujie Kan is often cited by papers focused on Berberine and alkaloids research (2 papers), Fibroblast Growth Factor Research (2 papers) and Nanoplatforms for cancer theranostics (1 paper). Mujie Kan collaborates with scholars based in China, Saint Kitts and Nevis and Canada. Mujie Kan's co-authors include Li Chen, Jing Li, Yue Pan, Xuewen Zhang, Xi Yang, Huiqing Xu, Xin Jiang, Caina Xu, Chang Liu and Yunjing Wang and has published in prestigious journals such as Applied Microbiology and Biotechnology, Molecules and Life Sciences.

In The Last Decade

Mujie Kan

12 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mujie Kan China	8	87	86	65	56	43	12	336
Thaís Gomes de Carvalho Brazil	15	161 1.9×	42 0.5×	93 1.4×	76 1.4×	61 1.4×	22	584
Michael Yuan‐Chien Chen Taiwan	13	281 3.2×	50 0.6×	60 0.9×	56 1.0×	31 0.7×	23	569
Marcelle Silva-Abreu Spain	13	112 1.3×	41 0.5×	17 0.3×	104 1.9×	58 1.3×	26	597
Rutusmita Mishra India	10	113 1.3×	39 0.5×	24 0.4×	100 1.8×	96 2.2×	17	458
Wenmin Pi China	8	92 1.1×	22 0.3×	54 0.8×	91 1.6×	78 1.8×	18	319
Swarnendu Bag India	12	123 1.4×	35 0.4×	72 1.1×	22 0.4×	22 0.5×	31	445
Vasanth Raj Palanimuthu India	11	172 2.0×	67 0.8×	31 0.5×	60 1.1×	40 0.9×	20	402
Jihui Lu China	10	103 1.2×	24 0.3×	61 0.9×	113 2.0×	96 2.2×	23	378
Xiaoyu Lin China	8	95 1.1×	22 0.3×	49 0.8×	101 1.8×	79 1.8×	17	331

Countries citing papers authored by Mujie Kan

Since Specialization

Citations

This map shows the geographic impact of Mujie Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mujie Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mujie Kan more than expected).

Fields of papers citing papers by Mujie Kan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mujie Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mujie Kan. The network helps show where Mujie Kan may publish in the future.

Co-authorship network of co-authors of Mujie Kan

This figure shows the co-authorship network connecting the top 25 collaborators of Mujie Kan. A scholar is included among the top collaborators of Mujie Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mujie Kan. Mujie Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Tang, Yixin, Huiqing Xu, Xue Wang, et al.. (2023). Advances in preparation and application of antibacterial hydrogels. Journal of Nanobiotechnology. 21(1). 300–300. 94 indexed citations

Liu, Chang, Xue Wang, Huiqing Xu, et al.. (2023). Research progress of polyphenols in nanoformulations for antibacterial application. Materials Today Bio. 21. 100729–100729. 58 indexed citations

Liu, Jiankai, Mujie Kan, Yuan Yue, et al.. (2022). Rapid Degradation of SARS-CoV-2 Spike S Protein by A Specific Serine Protease. Molecules. 27(6). 1882–1882. 2 indexed citations

Ren, Kai, et al.. (2021). Preliminary Study on the Antibacterial and Cytotoxic Effects of the Synthetic New Peptide NJP9-A. International Journal of Peptide Research and Therapeutics. 27(4). 2199–2207. 1 indexed citations

Liu, Yujing, et al.. (2016). Inhibitory Effects of Tranilast on Cytokine, Chemokine, Adhesion Molecule, and Matrix Metalloproteinase Expression in Human Corneal Fibroblasts Exposed to Poly(I:C). Current Eye Research. 41(11). 1400–1407. 9 indexed citations

Kan, Mujie, et al.. (2016). Expression, Purification and Characterization of Recombinant Canine FGF21 in Escherichia coli. Protein and Peptide Letters. 23(9). 785–789. 1 indexed citations

Zhao, Liping, Tianmin Xu, Mujie Kan, Yechen Xiao, & Manhua Cui. (2016). A novel uPAg-KPI fusion protein inhibits the growth and invasion of human ovarian cancer cells in vitro. International Journal of Molecular Medicine. 37(5). 1310–1316. 1 indexed citations

Li, Jing, Ou Li, Mujie Kan, et al.. (2015). Berberine induces apoptosis by suppressing the arachidonic acid metabolic pathway in hepatocellular carcinoma. Molecular Medicine Reports. 12(3). 4572–4577. 55 indexed citations

Zhang, Xiguang, Yan Sun, Huijing Xu, et al.. (2014). High-level expression, purification, and characterization of bifunctional ScFv-9R fusion protein. Applied Microbiology and Biotechnology. 98(12). 5499–5506. 11 indexed citations

10.

Li, Jing, Yue Pan, Mujie Kan, et al.. (2014). Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase. Life Sciences. 98(1). 24–30. 80 indexed citations

11.

Shao, Dan, Mujie Kan, Ping Qiao, et al.. (2014). Celecoxib induces apoptosis via a mitochondria-dependent pathway in the H22 mouse hepatoma cell line. Molecular Medicine Reports. 10(4). 2093–2098. 13 indexed citations

12.

Liu, Jiankai, Mujie Kan, Lin Gao, et al.. (2007). Morphine enhances purine nucleotide catabolism in vivo and in vitro. Acta Pharmacologica Sinica. 28(8). 1105–1115. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact